Titre du document / Document title
Type I interferons protect mice against enterovirus 71 infection
Auteur(s) / Author(s)
LIU Ming-Liang
(1) ;
LEE Yi-Ping
(2) ;
WANG Ya-Fang
(2) ;
LEI Huan-Yao
(1) ;
LIU Ching-Chuan
(3) ;
WANG Shih-Min
(3) ;
SU Lh-Jen
(4) ;
WANG Jen-Reng
(5) ;
YEH Trai-Ming
(5) ;
CHEN Shun-Hua
(1) ;
YU Chun-Keung
(1) ;
Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)
(1) Departments of Microbiology & Immunology, College of Medicine, National Cheng Kung University, Tainan, 70101, TAIWAN, PROVINCE DE CHINE
(2) Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, 70101, TAIWAN, PROVINCE DE CHINE
(3) Department of Pediatrics, College of Medicine, National Cheng Kung University, Tainan, 70101, TAIWAN, PROVINCE DE CHINE
(4) Department of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, 70101, TAIWAN, PROVINCE DE CHINE
(5) Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, 70101, TAIWAN, PROVINCE DE CHINE
Résumé / Abstract
In this study, the contribution of type I interferons (IFNs) to protection against infection with enterovirus 71 (EV71) was investigated using a murine model where the virus was administrated to neonatal Institute of Cancer Research (ICR) mice by either the intraperitoneal (i.p.) or the oral route. In i.p. inoculated mice, post-infection treatment of dexamethasone (5 mg kg
-1 at 2 or 3 days after infection) exacerbated clinical symptoms and increased the tissue viral titre. In contrast, polyriboinosinic : polyribocytidylic acid [poly(I : C); 10 or 100 μg per mouse at 12 h before infection], a potent IFN inducer, improved the survival rate and decreased the tissue viral titres after EV71 challenge, which correlated with an increase in serum IFN-a concentration, the percentage of dendritic cells, their expression of major histocompatibility complex class II molecule and IFN-a in spleen. Treatment with a neutralizing antibody for type I IFNs (10
4 neutralizing units per mouse, 6 h before and 12 h after infection) resulted in frequent deaths and higher tissue viral load in infected mice compared with control mice. In contrast, an early administration of recombinant mouse IFN-aA (10
4 U per mouse for 3 days starting at 0, 1 or 3 days after infection) protected the mice against EV71 infection. In vitro analysis of virus-induced death in three human cell lines showed that human type I IFNs exerted a direct protective effect on EV71. It was concluded that type I IFNs play an important role in controlling EV71 infection and replication.
Revue / Journal Title
Journal of general virology
ISSN 0022-1317
CODEN JGVIAY
Source / Source
2005, vol. 86 (12), pp. 3263-3269 [7 page(s) (article)] (31 ref.)
Langue / Language
Anglais
Editeur / Publisher
Society for General Microbiology, Reading, ROYAUME-UNI
(1967)
(Revue)
Mots-clés anglais / English Keywords
Virus ;
Picornaviridae ;
Vertebrata ;
Mammalia ;
Rodentia ;
Virology ;
Microbiology ;
Interferon ;
Enterovirus ;
Mouse ;
Mots-clés français / French Keywords
Virus ;
Picornaviridae ;
Vertebrata ;
Mammalia ;
Rodentia ;
Virologie ;
Microbiologie ;
Interféron ;
Enterovirus ;
Souris ;
Mots-clés espagnols / Spanish Keywords
Virus ;
Picornaviridae ;
Vertebrata ;
Mammalia ;
Rodentia ;
Virología ;
Microbiología ;
Interferón ;
Enterovirus ;
Ratón ;
Localisation / Location
INIST-CNRS, Cote INIST : 13533, 35400013546172.0090
Nº notice refdoc (ud4) : 17303561